slides · global inventory
Present Solution
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 24,547
Current window 14,341-14,370
Pages 819
Rows per page 30
Slide function
14,341-14,370 of 24,547
19
Uses a timeline-based value chain diagram to illustrate supply chain efficiency.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
26
The slide uses a process flow to illustrate brand evolution.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
34
The slide uses a combination of a photo background with overlaid text and two line charts to illustrate the trend of decreasing CapEx and improving EBITDA across various farm locations.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
35
Kalera | Investor Day Presentation Deck | 57 slidesKalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
38
The slide uses a comparative structure to show evolution from the Kuwait pilot to the Singapore next-gen facility.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
39
The slide uses flow diagrams to illustrate financial and operational relationships between TopCo, OpCo, AssetCo, and partners.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
45
Kalera | Investor Day Presentation Deck | 57 slidesKalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
49
Kalera | Investor Day Presentation Deck | 57 slidesKalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
50
Uses an icon-based visual metaphor to represent breeding cycles.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
51
Uses a metaphor of a control panel/sliders to represent genetic design.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
52
Kalera | Investor Day Presentation Deck | 57 slidesKalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
54
The slide uses a process-like flow with plus signs between columns, suggesting an additive or integrated strategic model.Kalera | Investor Day Presentation Deck | 57 slides · Kalera
Deck Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
08
The slide uses a waterfall-style buildup to explain how specific financial levers contribute to a 9-10% annual TSR target.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations 1 hit
32
The slide uses a waterfall-style buildup to explain the components of TSR.Levi Strauss | Investor Presentation Deck | 49 slides · Levi Strauss & Co.
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
11
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
12
The slide uses a color-coded border system to distinguish between test types (Qualitative/Quantitative Immunoassay, Enzyme, Molecular).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
14
The slide showcases the physical device and a series of color-coded test cartridges for various conditions (COVID-19, HbA1c, D-Dimer, etc.).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Solution (Provide relief)1 hit
16
The visual shows four distinct test strips (INR, D-Dimer, SARS CoV-2 Ab, SARS CoV-2 Ag) to demonstrate the 'common architecture' claim.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
17
The slide uses a numbered process flow (1-8) to explain the technical mechanism of the assay.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
18
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
19
The chart uses a bar-vertical format to show relative pricing, with LumiraDx POC positioned as significantly cheaper than other POC solutions.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
20
The diagram uses concentric circles to represent layers of IP protection (Manufacturing, Assays, Microfluidic Strip, Instrument).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
21
The slide uses a horizontal arrow at the bottom to represent the strategic shift toward 'Decentralization'.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
22
The slide displays the physical device on the right and a row of 10 distinct test cartridges on the left, representing the product pipeline.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
24
The slide uses a scatter plot to demonstrate method comparison between LumiraDx and a laboratory reference (bioMérieux Vidas).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
26
The slide uses a bulleted list for key value propositions and a table to demonstrate clinical sensitivity (PPA) across different Ct value thresholds.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Beat · Evidence1 hit
31
The slide illustrates a 3-step process: Prep Sample, Load & Run, and Report Results, with a timeline of 1 minute for prep and 2-12 minutes for results.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
32
Uses a visual 'before/after' style comparison with red X marks to indicate legacy/displaced systems.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
36
The slide uses a color-coded legend to distinguish between testing methodologies (Immunoassay, Molecular, Enzyme, Metabolic/Electrochemical).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
37
The slide emphasizes the breadth of the diagnostic menu available on a single hardware platform.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit